It has not been approved by the FDA or any other regulatory agency for clinical use
Consulting with a weight loss specialist, such as a bariatric surgeon or endocrinologist, is the best way to make sure youre using semaglutide safely and receiving proper follow-up care
With guidance from experts, treatment becomes reliable and trustworthy
Immediate medical attention is required if any of the following occur: Severe, persistent abdominal pain, particularly if radiating to the back (possible pancreatitis) Persistent vomiting preventing fluid intake for more than 24 hours Signs of dehydration: dark urine, dizziness, reduced urination, extreme thirst Symptoms of gallbladder disease: right upper abdominal pain, fever, jaundice Allergic reactions: rash, difficulty breathing, facial swelling For people with diabetes: worsening vision or diabetic retinopathy symptoms Symptoms of hypoglycaemia: shakiness, confusion, sweating, rapid heartbeat Pregnancy or suspected pregnancy (Wegovy is contraindicated in pregnancy) Patients should contact their GP or prescriber within a few days if they experience: Intolerable nausea or vomiting that persists beyond the first week of a new dose Severe constipation unresponsive to dietary changes and over-the-counter remedies Persistent diarrhoea lasting more than a few days Unusual or concerning weight loss patterns Mood changes, depression, or suicidal thoughts Thyroid symptoms: persistent hoarseness, lump in the neck, difficulty swallowing Concerns about medication interactions Routine follow-up appointments should be scheduled at regular intervals during re-titration, typically: Before restarting treatment (baseline assessment) After 8-12 weeks (mid-titration review) After reaching maintenance dose Every 3-6 months thereafter for ongoing monitoring These appointments allow monitoring of weight loss progress, assessment of side effects, review of dietary and lifestyle modifications, and evaluation of cardiovascular risk factors
Effects of oral supplementation with methylsulfonylmethane on skin health and wrinkle reduction
Collectively, our findings reinforce that OCTN2 functions as a highly selective, high affinity transporter, mediating carnitine uptake via a Na + -dependent mechanism that, to our knowledge, has not been observed in the SLC22 family or in MFS transporters more broadly
